EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Solvent Selection for Circular Designs – Bridging Process Needs and Sustainability Goals

Michael U Luescher, Alessia Valotta, Julien Haber, Fabrice Gallou

CHIMIA · 2025

DOI: 10.2533/chimia.2025.606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CHIMIA, 2025. Verfasst von Michael U Luescher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chemical & Analytical Development, Novartis Pharma AG, CH-4056 Basel, Switzerland.. michael-1.luescher@novartis.com. Hauptthemen laut MEDLINE: Drug Industry, Solvents. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmaceutical industries play a crucial role in enhancing global health outcomes; however, like many other sectors, they also encounter significant environmental challenges. The extraction of raw materials and the manufacture of active pharmaceutical ingredients (APIs) result in considerable waste production, substantial resource consumption, and environmental pollution. Transitioning from traditional linear economic models to circular processes presents an opportunity for more sustainable pharmaceutical operations that benefit both communities and the environment. The circular economy framework – grounded in resource efficiency, waste minimization, and material regeneration – offers a path towards comprehensive sustainability in pharmaceutical practices. This is particularly relevant in the area of solvent usage, which accounts for over half the input mass and associated waste in most processes. This article examines the application of circular economy principles to solvent selection within process design, highlighting its significance as a central component of sustainable pharmaceutical development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug IndustrySolventsSustainable Development

Stichwörter der Autor:innen

Circular economyDistallationLCASolvent selectionSustainable process development

Substanzen

Solvents

Autor:innen und Institutionen

  • Chemical & Analytical Development, Novartis Pharma AG, CH-4056 Basel, Switzerland.. michael-1.luescher@novartis.com.
  • Chemical & Analytical Development, Novartis Pharma AG, CH-4056 Basel, Switzerland.. alessia.valotta@novartis.com.
  • Chemical & Analytical Development, Novartis Pharma AG, CH-4056 Basel, Switzerland.. fabrice.gallou@novartis.com.

Zitieren

APA

Luescher, M. U., Valotta, A., Haber, J., & Gallou, F. (2025). Solvent Selection for Circular Designs – Bridging Process Needs and Sustainability Goals. CHIMIA. https://doi.org/10.2533/chimia.2025.606

Vancouver

Luescher MU, Valotta A, Haber J, Gallou F. Solvent Selection for Circular Designs – Bridging Process Needs and Sustainability Goals. CHIMIA. 2025. doi:10.2533/chimia.2025.606

BibTeX
@article{Luescher2025,
  author = {Luescher, Michael U and Valotta, Alessia and Haber, Julien and Gallou, Fabrice},
  title = {Solvent Selection for Circular Designs – Bridging Process Needs and Sustainability Goals},
  journal = {CHIMIA},
  year = {2025},
  doi = {10.2533/chimia.2025.606}
}
Kostenlos starten →